Professional Documents
Culture Documents
KEY FACTS
CVDs are the number one cause of death globally: more people die annually from CVDs
than from any other cause (1).
An estimated 17.3 million people died from CVDs in 2008, representing 30% of all
global deaths(1). Of these deaths, an estimated 7.3 million were due to coronary heart
disease and 6.2 million were due to stroke (2).
Low- and middle-income countries are disproportionally affected: over 80% of CVD
deaths take place in low- and middle-income countries and occur almost equally in men
and women (1).
The number of people who die from CVDs, mainly from heart disease and stroke, will
increase to reach 23.3. million by 2030 (1,3). CVDs are projected to remain the single
leading cause of death (3).
Most cardiovascular diseases can be prevented by addressing risk factors such as tobacco
use, unhealthy diet and obesity, physical inactivity, high blood pressure, diabetes and
raised lipids.
9.4 million deaths each year, or 16.5% of all deaths can be attributed to high blood
pressure (4). This includes 51% of deaths due to strokes and 45% of deaths due to
coronary heart disease (5).
coronary heart disease disease of the blood vessels supplying the heart muscle;
cerebrovascular disease - disease of the blood vessels supplying the brain;
peripheral arterial disease disease of blood vessels supplying the arms and legs;
rheumatic heart disease damage to the heart muscle and heart valves from rheumatic
fever, caused by streptococcal bacteria;
deep vein thrombosis and pulmonary embolism blood clots in the leg veins, which can
dislodge and move to the heart and lungs.
Heart attacks and strokes are usually acute events and are mainly caused by a blockage that
prevents blood from flowing to the heart or brain. The most common reason for this is a build-up
of fatty deposits on the inner walls of the blood vessels that supply the heart or brain. Strokes can
also be caused by bleeding from a blood vessel in the brain or from blood clots.
In addition the person may experience difficulty in breathing or shortness of breath; feeling sick
or vomiting; feeling light-headed or faint; breaking into a cold sweat; and becoming pale.
Women are more likely to have shortness of breath, nausea, vomiting, and back or jaw pain.
The most common symptom of a stroke is sudden weakness of the face, arm, or leg, most often
on one side of the body. Other symptoms include sudden onset of:
numbness of the face, arm, or leg, especially on one side of the body;
confusion, difficulty speaking or understanding speech;
fainting or unconsciousness.
Symptoms of rheumatic heart disease include: shortness of breath, fatigue, irregular heart
beats, chest pain and fainting.
Symptoms of rheumatic fever include: fever, pain and swelling of the joints, nausea,
stomach cramps and vomiting.
Treatment
Early treatment of streptococcal sore throat can stop the development of rheumatic fever.
Regular long-term penicillin treatment can prevent repeat attacks of rheumatic fever
which give rise to rheumatic heart disease and can stop disease progression in people
whose heart valves are already damaged by the disease.
Over 80% of the world's deaths from CVDs occur in low- and middle-income countries.
People in low- and middle-income countries are more exposed to risk factors such as
tobacco, leading to CVDs and other noncommunicable diseases. At the same time they
often do not have the benefit of prevention programmes compared to people in highincome countries.
People in low- and middle-income countries who suffer from CVDs and other
noncommunicable diseases have less access to effective and equitable health care
services which respond to their needs (including early detection services).
As a result, many people in low- and middle-income countries die younger from CVDs
and other noncommunicable diseases, often in their most productive years.
The poorest people in low- and middle-income countries are affected most. At the
household level, sufficient evidence is emerging to prove that CVDs and other
noncommunicable diseases contribute to poverty due to catastrophic health spending and
high out of pocket expenditure.
At macro-economic level, CVDs place a heavy burden on the economies of low- and
middle-income countries. Noncommunicable disease including cardiovascular disease
and diabetes are estimated to reduce GDP by up to 6.77% in low- and middle-income
countries experiencing rapid economic growth, as many people die prematurely (1).
Comprehensive action requires combining approaches that seek to reduce the risks
throughout the entire population with strategies that target individuals at high risk or with
established disease.
Examples of population-wide interventions that can be implemented to reduce CVDs
include: comprehensive tobacco control policies, taxation to reduce the intake of foods
that are high in fat, sugar and salt, building walking and cycle paths to increase physical
activity, providing healthy school meals to children.
Integrated approaches focus on the main common risk factors for a range of chronic
diseases such as CVD, diabetes and cancer: unhealthy diet, physically inactivity and
tobacco use.
There are several intervention options available. Some of these interventions can be implemented
even by non-physician health workers in close- to- client facilities. They are very cost effective
and high impact interventions and have been prioritized by WHO. For example:
People at high risk can be identified early in primary care, using simple tools such as
specific risk prediction charts. If people are identified early, inexpensive treatment is
available to prevent many heart attacks and strokes.
Survivors of a heart attack or stroke are at high risk of recurrences and at high risk of
dying from them. The risk of a recurrence or death can be substantially lowered with a
combination of drugs statins to lower cholesterol, drugs to lower blood pressure, and
aspirin.
In addition surgical operations are sometimes required to treat CVDs. They include
coronary artery bypass, balloon angioplasty (where a small balloon-like device is
threaded through an artery to open the blockage), valve repair and replacement, heart
transplantation, and artificial heart operations.
Medical devices are required to treat some CVDs. Such devices include pacemakers,
prosthetic valves, and patches for closing holes in the heart.
There is a need for increased government investment in prevention and early detection through
national programmes aimed at prevention and control of noncommunicable diseases including
CVDs.
http://www.who.int/mediacentre/factsheets/fs317/en/index.html